BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8412201)

  • 21. Retinoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis.
    Lippman SM; Benner SE; Hong WK
    Cancer Res; 1994 Apr; 54(7 Suppl):2025s-2028s. PubMed ID: 8137332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer chemoprevention.
    Lippman SM; Benner SE; Hong WK
    J Clin Oncol; 1994 Apr; 12(4):851-73. PubMed ID: 8151328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoid receptor cross-talk in respiratory epithelium cancer chemoprevention.
    Karamouzis MV; Papavassiliou AG
    Trends Mol Med; 2005 Jan; 11(1):10-6. PubMed ID: 15649817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Black tea (Camellia sinensis) as a chemopreventive agent in oral precancerous lesions.
    Halder A; Raychowdhury R; Ghosh A; De M
    J Environ Pathol Toxicol Oncol; 2005; 24(2):141-4. PubMed ID: 15831086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Micronuclei and carcinogen DNA adducts as intermediate end points in nutrient intervention trial of precancerous lesions in the oral cavity.
    Prasad MP; Mukundan MA; Krishnaswamy K
    Eur J Cancer B Oral Oncol; 1995 May; 31B(3):155-9. PubMed ID: 7549753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical experience with the micronucleus assay.
    Garewal HS; Ramsey L; Kaugars G; Boyle J
    J Cell Biochem Suppl; 1993; 17F():206-12. PubMed ID: 8412196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemoprevention of aerodigestive cancer.
    Berwick M; Schantz S
    Cancer Metastasis Rev; 1997; 16(3-4):329-47. PubMed ID: 9433643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premalignant changes in normal appearing epithelium in patients with squamous cell carcinoma of the upper aerodigestive tract.
    Incze J; Vaughan CW; Lui P; Strong MS; Kulapaditharom B
    Am J Surg; 1982 Oct; 144(4):401-5. PubMed ID: 7125069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung cancer chemoprevention: ACCP evidence-based clinical practice guidelines (2nd Edition).
    Gray J; Mao JT; Szabo E; Kelley M; Kurie J; Bepler G;
    Chest; 2007 Sep; 132(3 Suppl):56S-68S. PubMed ID: 17873160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasia.
    Lam S; Xu X; Parker-Klein H; Le Riche JC; Macaulay C; Guillaud M; Coldman A; Gazdar A; Lotan R
    Int J Oncol; 2003 Dec; 23(6):1607-13. PubMed ID: 14612933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoids and chemoprevention: clinical and basic studies.
    Lippman SM; Heyman RA; Kurie JM; Benner SE; Hong WK
    J Cell Biochem Suppl; 1995; 22():1-10. PubMed ID: 8538183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinoid chemoprevention of upper aerodigestive tract carcinogenesis.
    Lippman SM; Hong WK
    Important Adv Oncol; 1992; ():93-109. PubMed ID: 1316312
    [No Abstract]   [Full Text] [Related]  

  • 33. Biomarkers as intermediate end points in chemoprevention trials.
    Lippman SM; Lee JS; Lotan R; Hittelman W; Wargovich MJ; Hong WK
    J Natl Cancer Inst; 1990 Apr; 82(7):555-60. PubMed ID: 2179569
    [No Abstract]   [Full Text] [Related]  

  • 34. Dietary risk factors for upper aerodigestive tract cancers.
    Kasum CM; Jacobs DR; Nicodemus K; Folsom AR
    Int J Cancer; 2002 May; 99(2):267-72. PubMed ID: 11979443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the Bowman-Birk inhibitor for oral cancer chemoprevention and analysis of Neu immunohistochemical staining intensity with Bowman-Birk inhibitor concentrate treatment.
    Armstrong WB; Wan XS; Kennedy AR; Taylor TH; Meyskens FL
    Laryngoscope; 2003 Oct; 113(10):1687-702. PubMed ID: 14520092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of biomarkers by chemopreventive agents in smoke-exposed rats.
    Izzotti A; Balansky RM; Dagostini F; Bennicelli C; Myers SR; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 2001 Mar; 61(6):2472-9. PubMed ID: 11289117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of lung cancer and the modulation of markers of chronic carcinogen exposure by chemopreventive agents.
    Perera FP; Tang D; Grinberg-Funes RA; Blackwood MA; Dickey C; Blaner W; Santella RM
    J Cell Biochem Suppl; 1993; 17F():119-28. PubMed ID: 8412183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomolecular markers as intermediate end points in chemoprevention trials of upper aerodigestive tract cancer.
    Papadimitrakopoulou VA; Hong WK
    Int J Cancer; 2000 Dec; 88(6):852-5. PubMed ID: 11093804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current status and prospects of chemoprevention in oral squamous epithelial carcinomas and precancerous lesions].
    Zöller JE; Scheer M
    Mund Kiefer Gesichtschir; 2000 May; 4 Suppl 1():S160-8. PubMed ID: 10938656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectiveness of beta-carotene in cancer chemoprevention.
    Toma S; Losardo PL; Vincent M; Palumbo R
    Eur J Cancer Prev; 1995 Jun; 4(3):213-24. PubMed ID: 7647689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.